Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer

Journal of Nuclear Medicine

Volumn 41, Issue 10, 2000, Pages 1689-1694

  Kolesnikov Gauthier, H ^a   Carpentier, P ^a   Depreux, P ^a   Vennin, P ^a   Caty, A ^a   Sulman, C ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

186Re; Bone metastasis; Breast carcinoma; Prostate carcinoma; Radionuclide targeted radiotherapy

Indexed keywords

ETIDRONIC ACID RE 186;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; BONE METASTASIS; BREAST CARCINOMA; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EDEMA; ERYTHEMA; EXOPHTHALMOS; FEMALE; HEART FAILURE; HUMAN; MALE; PAIN ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CARCINOMA; PRURITUS; RADIOISOTOPE THERAPY;

ADENOCARCINOMA; AGED; BONE NEOPLASMS; BREAST NEOPLASMS; ETIDRONIC ACID; FEMALE; HUMAN; MALE; MIDDLE AGE; PALLIATIVE CARE; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RHENIUM; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0033781698     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bone metastases: Prognosis, diagnosis and treatment
2. Natural history, prognosis and staging of bone metastases
3. Frequency of pain in patients with cancer
4. Drug therapy: Management of cancer of the prostate
5. Bone metastases: Pathophysiology and management policy
6. The palliation of symptomatic osseous metastases: Final results of the study by the Radiation Therapy Oncology Group
7. Single dose half body irradiation for palliation of multiple bone metastases from solid tumors: Final Radiation Therapy Oncology Group report
8. Re-186 (Sn) HEDP for treatment of painful osseous metastases: Initial clinical experience in 20 patients with hormone-resistant prostate cancer
9. Rhenium-186 (Sn) HEDP for treatment of painful osseous metastases: Result of a double-blind crossover comparison with placebo
10. Targeted radionuclide therapy for bone metastases
11. Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain
12. Results of a randomised phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant prostate cancer
13. Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases
14. Re-186-HEDP for treatment of painful bone metastases in patients with metastatic prostate or breast cancer: Preliminary results
15. Evaluation of the use of a pain diary in chronic cancer pain patients at home
16. Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer
17. Safety and efficacy of repeated sequential administration of Re-186 (Sn) HEDP as palliative therapy for painful skeletal metastases: Initial case reports of two patients